Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
Clinical trial NCT04762680 · COMPLETED
Trial details
- NCT number
- NCT04762680
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2023-06-29
- Enrollment
- 3159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.